Table 1.
Maternal clinical and laboratory characteristics of COVID-19, SARS, and MERS in pregnancy.
| References | Patient no. (disease + number) | Trimester | Nationality | Age (years) | GA on Admission (weeks) | Fever | Cough | Myalgia | Malaise | Dyspnea | Signs of viral pneumonia on CT | Lymphopenia |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhao et al. (2020) | COVID-19-1 | 2nd | China | 38 | 25 + 5 | Yes | Yes | No | Yes | Yes | Yes | Yes |
| Chen H. et al. (2020) | COVID-19-2 | 3rd | China | 33 | 37 + 2 | No | Yes | No | No | No | Yes | No |
| Chen H. et al. (2020) | COVID-19-3 | 3rd | China | 27 | 38 + 2 | Yes | Yes | Yes | No | No | Yes | Yes |
| Chen H. et al. (2020) | COVID-19-4 | 3rd | China | 40 | 36 | No | Yes | No | No | No | Yes | Yes |
| Chen H. et al. (2020) | COVID-19-5 | 3rd | China | 26 | 36 + 2 | Yes | No | No | No | Yes | Yes | No |
| Chen H. et al. (2020) | COVID-19-6 | 3rd | China | 26 | 38 + 1 | Yes | No | Yes | Yes | No | Yes | Yes |
| Chen H. et al. (2020) | COVID-19-7 | 3rd | China | 26 | 36 + 3 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Chen H. et al. (2020) | COVID-19-8 | 3rd | China | 29 | 36 + 2 | Yes | No | No | No | No | No | Yes |
| Chen H. et al. (2020) | COVID-19-9 | 3rd | China | 28 | 38 | Yes | No | No | No | No | Yes | No |
| Chen H. et al. (2020) | COVID-19-10 | 3rd | China | 34 | 39 + 4 | Yes | No | No | No | No | Yes | No |
| Yu et al. (2020) | COVID-19-11 | 3rd | China | 34 | 39 + 6 | Yes | No | No | No | No | Yes | Yes |
| Yu et al. (2020) | COVID-19-12 | 3rd | China | 30 | 38 + 5 | Yes | No | No | No | Yes | Yes | No |
| Yu et al. (2020) | COVID-19-13 | 3rd | China | 31 | 41 + 2 | Yes | No | No | No | No | Yes | Yes |
| Yu et al. (2020) | COVID-19-14 | 3rd | China | 33 | 37 | No | Yes | No | No | No | Yes | Yes |
| Yu et al. (2020) | COVID-19-15 | 3rd | China | 29 | 40 + 4 | Yes | No | No | No | No | Yes | No |
| Yu et al. (2020) | COVID-19-16 | 3rd | China | 34 | 38 + 2 | Yes | No | No | No | No | Yes | Yes |
| Yu et al. (2020) | COVID-19-17 | 3rd | China | 34 | 38 + 4 | Yes | No | No | No | No | Yes | Yes |
| Zhu et al. (2020) | COVID-19-18 | 3rd | China | 25 | — | Yes | No | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-19 | 3rd | China | 35 | — | Yes | No | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-20 | 3rd | China | 35 | — | No | Yes | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-21 | 3rd | China | 30 | — | Yes | No | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-22 | 3rd | China | 30 | — | Yes | No | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-23 | 3rd | China | 30 | — | Yes | Yes | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-24 | 3rd | China | 30 | — | Yes | Yes | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-25 | 3rd | China | 29 | — | Yes | Yes | No | No | No | Yes | — |
| Zhu et al. (2020) | COVID-19-26 | 3rd | China | 34 | — | Yes | No | No | No | No | Yes | — |
| Chen S. et al. (2020) | COVID-19-27 | 3rd | China | 23 | 37 + 3 | Yes | No | No | No | Yes | Yes | No |
| Chen S. et al. (2020) | COVID-19-28 | 3rd | China | 34 | 38 + 6 | Yes | No | No | No | No | Yes | No |
| Chen S. et al. (2020) | COVID-19-29 | 3rd | China | 32 | 35 | Yes | No | No | No | No | Yes | No |
| Wong et al. (2004) | SARS-1 | 1st | China | 33 | 4 | Yes | Yes | Yes | Yes | No | Yes | No |
| Wong et al. (2004) | SARS-2 | 1st | China | 34 | 4 | Yes | No | Yes | Yes | No | Yes | No |
| Wong et al. (2004) | SARS-3 | 1st | China | 44 | 4 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Wong et al. (2004) | SARS-4 | 1st | China | 24 | 3 | Yes | Yes | Yes | No | No | Yes | No |
| Wong et al. (2004) | SARS-5 | 1st | China | 24 | 6 | Yes | No | Yes | Yes | No | Yes | Yes |
| Wong et al. (2004) | SARS-6 | 1st | China | 25 | 12 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Wong et al. (2004) | SARS-7 | 1st | China | 26 | 3 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Wong et al. (2004) | SARS-8 | 2nd | China | 32 | 26 | Yes | No | Yes | Yes | No | Yes | No |
| Zhang et al. (2003) | SARS-9 | 2nd | China | 34 | 27 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Zhang et al. (2003) | SARS-10 | 2nd | China | — | 25 + 2 | Yes | Yes | No | Yes | No | Yes | Yes |
| Robertson et al. (2004) | SARS-11 | 2nd | — | — | 15 + 2 | Yes | Yes | No | No | No | Yes | Yes |
| Yudin et al. (2005) | SARS-12 | 2nd | Canada | 36 | 19 | Yes | Yes | No | No | Yes | Yes | Yes |
| Wong et al. (2004) | SARS-13 | 3rd | China | 33 | 31 | Yes | Yes | No | No | No | Yes | Yes |
| Wong et al. (2004) | SARS-14 | 3rd | China | 27 | 28 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Wong et al. (2004) | SARS-15 | 3rd | China | 30 | 30 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Wong et al. (2004) | SARS-16 | 3rd | China | 34 | 32 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Zhang et al. (2003) | SARS-17 | 3rd | China | — | 30 + 2 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Zhang et al. (2003) | SARS-18 | 3rd | China | — | 36 | Yes | Yes | No | No | No | Yes | Yes |
| Zhang et al. (2003) | SARS-19 | 3rd | China | — | 40 + 4 | Yes | No | No | No | No | Yes | Yes |
| Alfaraj et al. (2019) | MERS-1 | 1st | Saudi Arabia | 29 | 6 | No | No | No | No | No | — | — |
| Payne et al. (2014) | MERS-2 | 2nd | Jordanian | 39 | 5 months | Yes | Yes | No | Yes | No | — | — |
| Assiri et al. (2016) | MERS-3 | 2nd | Saudi Arabia | 27 | 22 | Yes | Yes | No | No | Yes | Yes | — |
| Assiri et al. (2016) | MERS-4 | 2nd | Saudi Arabia | 30 | 23 | Yes | Yes | No | No | Yes | — | — |
| Alfaraj et al. (2019) | MERS-5 | 2nd | Saudi Arabia | 39 | 24 | No | No | No | No | No | — | — |
| Assiri et al. (2016) | MERS-6 | 2nd | Saudi Arabia | 31 | 24 | No | Yes | Yes | No | Yes | Yes | — |
| Alserehi et al. (2016) | MERS-7 | 3rd | Saudi Arabia | 33 | 31 | Yes | Yes | No | No | Yes | Yes | — |
| Malik et al. (2016) | MERS-8 | 3rd | United Arab Emirates | 32 | 32 | Yes | Yes | No | No | Yes | Yes | — |
| Assiri et al. (2016) | MERS-9 | 3rd | Saudi Arabia | 34 | 34 | No | No | No | No | Yes | Yes | — |
| Park et al. (2016) | MERS-10 | 3rd | South Korean | 39 | 35 + 4 | No | No | Yes | No | No | Yes | — |
| Assiri et al. (2016) | MERS-11 | 3rd | Saudi Arabia | 32 | 38 | Yes | Yes | No | No | Yes | Yes | — |
GA, gestational age; COVID-19, 2019 novel coronavirus disease; SARS, severe acute respiratory syndrome coronavirus; MERS, Middle East Respiratory Syndrome coronavirus; CT, computed tomography; —, no data.